Guardant HealthGH
NASDAQMedical Laboratories
No cached AI snapshot yet for GH.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
2,506 employees131.17M shares outstandinglisted 2018-10-04
Next earnings ~May 5, 2026
About Guardant Health
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Latest News
Showing market-wide stock news
GoldHaven Confirms LIFE Offering Terms
Dollar hovers around two-month high as Iran-Israel truce hangs in balance
Asia stocks make tentative bounce, bonds pressured
The stock market just got crushed. Why Citi is raising its S&P 500 target.
Franklin Templeton flags critical dividend turning point
A Closer Look At Full-Time And Part-Time Employment: May 2026
Related Stocksin Medical Laboratories
Ready to see the live AI view on GH?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing GH side-by-side with live signals.